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Abstract
Original antigenic sin is the phenomenon in which prior exposure to an antigen leads to a subsequent suboptimal immune
response to a related antigen. Immune memory normally allows for an improved and rapid response to antigens previously
seen and is the mechanism by which vaccination works. I here develop a dynamical system model of the mechanism of
original antigenic sin in influenza, clarifying and explaining the detailed spin-glass treatment of original antigenic sin. The
dynamical system describes the viral load, the quantities of healthy and infected epithelial cells, the concentrations of naı ¨ve
and memory antibodies, and the affinities of naı ¨ve and memory antibodies. I give explicit correspondences between the
microscopic variables of the spin-glass model and those of the present dynamical system model. The dynamical system
model reproduces the phenomenon of original antigenic sin and describes how a competition between different types of B
cells compromises the overall effect of immune response. I illustrate the competition between the naı ¨ve and the memory
antibodies as a function of the antigenic distance between the initial and subsequent antigens. The suboptimal immune
response caused by original antigenic sin is observed when the host is exposed to an antigen which has intermediate
antigenic distance to a second antigen previously recognized by the host’s immune system.
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Introduction
An immune memory comes from a previous infection or
vaccination, stores the information for antigen recognition, and is
activated in a future infection by a related pathogen. Long-term
immune memory has been observed in various pathogens
including smallpox [1], malaria [2], hepatitis B [3], dengue [4],
and influenza A [5]. By recognizing and rapidly eliminating the
reinfecting pathogen, this long-lasting effect can permanently or
temporarily prevent the reinfection of the host by some pathogens
[6]. In some cases, this long-lasting effect can also reduce the
severity, duration, or risk of the infection and symptoms [7].
Smallpox virus, also called variola virus, only propagates in
humans and has a relatively low mutation rate [8]. In contrast,
influenza A virus propagates in humans, pigs, and aquatic birds,
with a higher mutation rate that is approximately 2:0|10{6/
nucleotide/infectious cycle [9], or 1:6|10{5/amino acid/day.
Calculation of the binding free energy between human antibodies
and circulating influenza A strains shows that the virus mutates
away from the genotypes that code for hemagglutinin proteins well
recognized by the human immune system [10]. Thus for influenza
A, there is usually a significant antigenic distance between the
circulating strain in a given year and the immune memory from
previous years.
Original antigenic sin is the phenomenon in which prior
exposure to an antigen leads to a subsequent suboptimal immune
response to a related antigen [11–13]. In some years when the
antigenic distances between vaccine and circulating virus strains
fell into a certain range, the effect of original antigenic sin
decreased the effectiveness of influenza vaccines. Historical data of
influenza vaccines indicate that vaccine effectiveness does not
monotonically decrease with the antigenic distance between the
vaccine strains and the circulating strains, but rather has a
minimum at an intermediate antigenic distance [14,15]. Interest-
ingly, since the vaccine effectiveness at this intermediate antigenic
distance between the vaccine and circulating strains is lower than
the effectiveness at a larger antigenic distance in unvaccinated
people, original antigenic sin could make vaccinated people more
susceptible to the virus than those who are unvaccinated.
The mechanism of original antigenic sin was previously studied
using stochastic models at the cellular level [16,17]. These
previous studies developed stochastic models with thousands to
millions of B cells [16,17]. The stochastic models introduce various
antigens to a repertoire of B cells. The B cells with higher affinity
to an antigen have larger probability to be selected during the B
cell maturation process. Earlier works discussing the mechanism of
original antigenic sin at the cellular level include [17], which
attributed original antigenic sin to the localization of the B cells in
the secondary immune response around the B cells in the primary
immune response in the amino acid sequence space. The affinity
between an antibody and an antigen is given by the generalized
NK model (GNK model) of the three-dimensional protein
structures [18]. The GNK model was derived from the NK
model which was originally introduced to model rugged fitness
landscapes [19,20] and evolutionary processes [21–23]. In the
GNK model, the amino acid sequences of a group of influenza A
specific antibodies are allowed to mutate freely and independently
in the affinity landscape to maximize their affinities to the virus. B
cells that produce antibodies with the highest affinities replicate
into the next generation. The mutation of the virus is modeled by
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of the simulation correlate well with the vaccine effectiveness data
observed in history [14].
The present study aims to use a set of ordinary differential
equations (ODEs) to describe the interaction among the B cells,
the virus particles, and the epithelial cells. This deterministic
model can reduce the memory and CPU requirements, compared
to the stochastic models [16,17]. In this study, I developed a set of
ODEs as the mean-field approximation of the stochastic models
that store the information of each B cell. The ODEs give a
deterministic explanation of original antigenic sin. This explana-
tion agrees with both the observed data [14] and a previous
explanation given by the GNK model [17]. Various ODE models
have been established to describe and simulate the process of
influenza A infection and the resulting immune response [24–29].
The basic elements of these ODE models were described in [30].
Automata have also been used to model the time-dependent
spatial distribution of the tissue cells and the virus [31,32].
In this study, I build a deterministic ODE-based model
compatible with the previous GNK model [17] to reproduce the
observed phenomenon of original antigenic sin. The main purpose
of this paper is to address the following two questions on the
modeling of original antigenic sin. First, can a deterministic
dynamical model with a small number of state variables simulate
the phenomenon of original antigenic sin, which was simulated by
stochastic models of a large repertoire of B cells [16,17]? Second,
what is the mechanism of original antigenic sin revealed by the
deterministic dynamical model? I address the first question by
building a deterministic ODE model, which reproduces the
phenomenon of original antigenic sin observed in experiment [11–
13]. See the subsections Model Development and Description,
Time Courses of Infection and Recovery, and A General Picture
of Original Antigenic Sin in the section Results. I address the
second question by analyzing the non-monotonicity of the overall
effect of an immune response. See the subsection Mechanism of
Original Antigenic Sin in the section Results. The values of the
parameters mainly come from previous studies that simulated
influenza infection and immune response and obtained plausible
results. However, the limitations of the available experimental data
do not allow one to develop an accurate model purely based upon
experimental data [33]. Experimental data available for model
development usually have limited quality or quantity, causing
unavoidable overparameterization of the models. In the present
dynamical model, two parameters c0 and s need to be estimated
prior to the simulation. I give the estimation of parameters c0 and
s in the section Materials and Methods and perform the sensitivity
analysis of both of them in the section Results. The terms in the
ODEs have clear physical meanings, so my model explicitly
illustrates the details of the influenza A infection and the immune
response. A comparison between this deterministic dynamical
model and previous stochastic models is presented in the section
Discussion. A brief review of the influenza A genome is in
Appendix S1.
Results
Model Development and Description
I use a simplified model consisting of the major components of
an immune response, which are epithelial cells, influenza A
viruses, and an immune system, to describe the dynamics of an
influenza A infection and the subsequent immune response. This
model contains six state variables, which are the healthy cell
concentration H ðÞ , the infected cell concentration I ðÞ , the viral
load V ðÞ , the concentrations of naı ¨ve and memory antibodies
X1 and X2 ðÞ , respectively, and the naı ¨ve antibody affinity U1 ðÞ .
These state variables are in Table 1.
This model comes from the following information on influenza
A infection. The concentration of epithelial cells on the upper
respiratory tract is around a fixed homeostatic level H0, which is
also the sum of the concentrations of healthy cells (H), of infected
cells (I), and of dead cells (D) killed by the influenza A virus,
respectively. Free influenza A virus particles (V) are released from
infected cells and are eliminated by influenza A specific antibodies.
I only consider virus clearance by antibodies, because a T cell can
recognize influenza A strains with different antigenic characters
[34]. This model has two types of antibodies: the naı ¨ve antibodies
and the memory antibodies generated by the last influenza A
infection or vaccination. The concentrations of the naı ¨ve and the
memory antibodies are defined as X1 and X2, respectively. The
immune system cleared the influenza A viruses bound by
antibodies. With the definition of antibody affinity
Ka~
Ag : Ab ½ 
Ag ½  Ab ½ 
, ð1Þ
the concentration of influenza A virus particles bound by
antibodies Ag : Ab ½  is proportional to the concentrations of the
free influenza A virus particles Ag ½  and of the influenza A specific
antibodies Ab ½  . The naı ¨ve and memory antibodies have affinities
U1 and U2, respectively, to the influenza A virus. The affinity of
memory antibodies, U2, is a constant parameter of the model. The
maximum affinity is defined as Umax. Here U1 and U2 are
quantified using the reduced unit 1:0|107 M{1, as described in
the subsection Reduced Units and Parameter Estimation in the
section Materials and Methods. Thus the affinities U1 and U2 are
defined as Ui~Ka=1:0|107 M{1 (i~1,2). The maximum affinity
is Umax~1 when Ka~1:0|107 M{1.
From the above information, a minimal set of ODEs are built to
model the influenza A specific immune response of co-existing
naı ¨ve antibodies with a low initial affinity and memory antibodies
with a higher and constant affinity. The state variables
Z~ H,I,V,X1,X2,U1 ðÞ comprise the healthy cell concentration
H, the infected cell concentration I, the viral load V, the naı ¨ve
Table 1. Descriptions and units of the variables of the
dynamical model.
Variable Description Unit
H Healthy cell concentration 1:7|10{11 M
I Infected cell concentration 1:7|10{11 M
V Viral load 1:7|10{11 M
X1 Concentration of naı ¨ve
antibodies recognizing
the virus
1:7|10{11 M
X2 Concentration of memory
antibodies from a previous
infection or vaccination
1:7|10{11 M
U1 Affinity of naı ¨ve antibodies
recognizing the virus
1:0|107 M{1
U2 Affinity of memory antibodies
from a previous infection or
vaccination
1:0|107 M{1
D Dead cell concentration 1:7|10{11 M
doi:10.1371/journal.pone.0023910.t001
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X2, and the binding affinity of naı ¨ve antibodies U1.
dH
dt
~lD{bVH ð2Þ
dI
dt
~bVH{aI ð3Þ
dV
dt
~kI{mV{pU 1X1V{pU 2X2V ð4Þ
dX1
dt
~c Z,t ðÞ
U1X1
U1X1zU2X2
{bX1 ð5Þ
dX2
dt
~c Z,t ðÞ
U2X2
U1X1zU2X2
{bX2 ð6Þ
dU1
dt
~sU 1X1VU max{U1 ðÞ : ð7Þ
The homeostasis of epithelial cells gives an additional algebraic
equation for the dead cell concentration, D,
D~H0{H{I: ð8Þ
Equation 2 describes the dynamics of the concentration of
healthy epithelial cells. The repair mechanism for epithelial tissue
is activated only if any damage in epithelial cells is detected
(D=0), and new healthy cells are regenerated with the rate lD to
repair the damaged tissue [25]. Alternative models for this repair
mechanism include regeneration rate~l [28] or lDH [29]. In
the stochastic model in [32], the regeneration rate is 0 when D~0
and has a mathematical expectation of lH when D=0. The
average life span of human trachea cells is 47.5 days [35], while
the time for epithelial cell regeneration is 0.3–1 day [25,36],
showing that the cell regeneration rate is significantly higher than
the normal cell division rate. With this consideration in mind, I
select the expression lD as the cell regeneration rate [25]. The
infection rate b represents the speed in which influenza A virus
converts healthy cells into infected cell. The protective effect of
interferon is neglected in this simplified model.
Equation 3 characterizes the dynamics of the infected cell
concentration. All the infected cells are converted from healthy
cells. Infected cells are killed by the virus with the rate a.
Equation 4 depicts the generation and elimination of virus
particles. Virus particles are released from infected cells with the
rate k. The half-life of free virus particles is 1=m. Viruses bound by
antibodies are neutralized and cleared by the immune system.
Thus the virus clearance rate is proportional to the concentration
of viruses bound by antibodies Ag : Ab ½  . From equation 1, the
virus clearance rate is proportional to the antibody affinity Ui
(i~1,2), the antibody concentration Xi (i~1,2), and the viral load
V, respectively.
Equations 5 and 6 show the secretion and decay of naı ¨ve
antibodies and memory antibodies. Antigen presenting cells (APC)
process the virus and present the antigen on their surface,
activating naı ¨ve T cells. Some of these activated T cells proliferate
and differentiate into Th2 helper T cells. Th2 cells and free virions
activate B cells together [37]. The intensity of activation signal for
B cells, c Z,t ðÞ , is a function of time depending on viruses, APCs,
and naı ¨ve T cells. The intensity c Z,t ðÞ is a rectangular window
function with the maximum value of c0, and is further described in
the section Materials and Methods. Naı ¨ve B cells mature in
germinal centers, undergoing proliferation and somatic hypermu-
tation. B cells are selected by competing for antigen binding and
activation signals from Th2 cells surrounding the germinal center.
The morphology of germinal centers determines that the interface
between the B cell region and the Th2 cell region is approximately
constant, and so is the amount of antigens inside the germinal
center. Therefore B cells inside the germinal center compete with
each other for the activation signal. The ratio of the intensities of
the activation signals for naı ¨ve and for memory B cells is
U1X1=U2X2. The decay rate of both naı ¨ve and memory
antibodies is b. I use identical decay rate (b) for naı ¨ve antibodies
(X1) in equation 5 and memory antibodies (X2) in equation 6
because the decay rate is independent of the type of antibodies
[38].
Equation 7 indicates that the increase rate of the affinity is
proportional to the concentration of the antigen-antibody
complex. Because the B cells are selected by the affinity to the
antigen in their maturation process, the increase of the naı ¨ve
antibody affinity U1 is driven by successful binding between the
naı ¨ve antibody and the antigen. The logistic factor Umax{U1 ðÞ
ensures that the probability for B cells to mutate to a state of
higher affinity decreases as the maturation proceeds.
The dynamical model comprises equations 2–7. Equations 2, 3,
4, and 7 are adapted from previous models [24,25,29]. Note that
equations 2, 3, 4, and 7 are not identical to their original form in
literature. Most of these previous models were developed
according to the processes of cell death and regeneration and
virus entry and release. The parameters of these models come
from experiment except for the parameter c0, which describes the
activation of B cells, and for the parameter s, which describes the
B cell maturation process. The parameter s was fit to experimental
data in a previous model [29]. As will be shown, I estimate the
values of c0 and s all over again and perform a sensitivity analysis
to the parameters c0 and s.
The present six-ODE model is able to be mapped from a
previous 10-ODE model developed by Hancioglu et al. [29].
Hancioglu et al.’s model contains 10 state variables, which are V
(virus), H (healthy cells), I (infected cells), M (antigen presenting
cells), F (interferons), R (virus resistant cells), E (cytotoxic T cells),
P (plasma cells), A (antibodies), and S (antigenic distance between
the antibody and the virus). Out of these 10 state variables, five
variables V, H, I, A, and S are also the state variables of my
model, and the other five variables M, F, R, E, and P are
incorporated into my model in a mean-field approach. In
Hancioglu et al.’s model, state variables M and P inhibit virus
growth by increasing the concentration of antibody (A), while state
variables F, R, and E reduce the concentration of infected cells (I)
that produce virus. In my model, the intensity of activation signal
for B cells is the term c Z,t ðÞ in equations 5 and 6. Compared to
Hancioglu et al.’s 10-ODE model, my six-ODE model removes
five state variables, while using two state variables X1 and X2 for
the naı ¨ve and memory antibodies, respectively.
Time Courses of Infection and Recovery
With all parameters defined and fixed in the section Materials
and Methods, I use the stiff differential equation solver ode23s in
MATLAB to numerically solve equations 2–7. The relative and
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respectively. The first set of parameters listed in the left column of
Table 2 are adopted. As described in the subsection Kinetics of
Influenza A Virus Infection in the section Materials and Methods,
at the moment of infection, all the epithelial cells are healthy cells,
and the initial viral load is approximately 1% of the epithelial cell
concentration. The concentration of naı ¨ve antibodies capable of
recognizing the antigen is approximately 10{4 of the epithelial cell
concentration, while the concentration of memory antibodies
specific to the antigen is 10{2 of the epithelial cell concentration.
Initial affinity of naı ¨ve antibodies to the antigen is 104 M{1, 10{3
of the maximum affinity. Using the reduced units introduced
in the section Materials and Methods, the initial values
Z 0 ðÞ ~ H 0 ðÞ ,I 0 ðÞ ,V 0 ðÞ ,X1 0 ðÞ ,X2 0 ðÞ ,U1 0 ðÞ ðÞ ~ 1,0,10{2,10{4,
 
10{2,10{3Þ. I run a simulation of 20 days. The solved trajectories
of the state variables Z are compared to the kinetics of influenza A
infection observed in reality to verify the model parameters.
I use two cases to illustrate the dynamics of all state variables. In
the first case, the virus has substantially mutated from the previous
strains, and the binding affinity of the memory antibodies to the
virus is low. In the second case, there is no significant escape
mutation of the virus, and the binding affinity of the memory
antibodies to the virus is high. The affinity of memory antibodies is
U2~10{3 in the first case and is U2~0:5 in the second case. The
details of the model dynamics are shown in Figure 1 and 2.
Figure 1 describes the whole process of influenza A virus
infection and clearance in humans without immune memory
(U2~10{3). A symptom with approximately 30% of the epithelial
cells killed is observed after the infection. The peak of the dead cell
concentration D occurs on Day 1 to Day 2, agreeing with the
experimental data [25]. On Day 5, the dead cell concentration D
falls under 0.1. The viral load V decreases to the initial level on
Day 3 to Day 4. A 105-fold increase of the naı ¨ve antibody
concentration occurs in the virus infection and clearance process.
The naı ¨ve antibody affinity U1 approaches to the maximum
Umax~1. The memory antibody concentration X2 has an initial
102-fold increase, and decreases approximately exponentially after
Day 1 with the rate 0.0427, similar to the antibody decay rate
b~0:043. Thus few memory antibodies are produced after Day 1.
Figure 2 shows the dynamics of virus infection and clearance
with immune memory (U2~0:5). Few dead cells are accumulated
and thus no symptoms are observable in the infected person. The
viral load is remarkably suppressed compared to Figure 1. Figure 2
depicts the effect of a successful vaccination. Compared to
Figure 1, the increase of the naı ¨ve antibodies concentration is
absent, and the naı ¨ve antibody concentration, X1, decreases
approximately exponentially with the rate 0.0423, close to the
antibody decay rate b~0:043, indicating that naı ¨ve antibodies are
rarely produced during the whole process of virus infection and
clearance. No significant somatic hypermutation is observed in
those naı ¨ve B cells. The naı ¨ve antibody affinity U1 is almost
constant, as shown by the plot of U1 against t. There is a notable
increase in the memory antibody concentration X2: the value of
X2 on Day 7 is approximately 10-fold higher than that in Figure 1.
The immune response is dominated by the naı ¨ve antibodies
when the memory antibodies have low affinity and is dominated
by the memory antibodies when they have high affinity. The
transition between these two cases occurs when the value of the
memory antibody affinity U2 falls into a critical region. In the
following subsection, U2 is set to a variety of values in the range
10{3ƒU2ƒ1. As the value of U2 changes, the phenomenon of
original antigenic sin can be observed in other characters of the
dynamics, such as the maximum percentage of dead cells, the
maximum viral load, the cumulative effects of naı ¨ve antibodies
and of memory antibodies, and the average antibody affinity. This
model is able to reproduce the phenomenon of original antigenic
sin observed in the experimental data at intermediate memory
antibody affinity U2.
A General Picture of Original Antigenic Sin
To illustrate the phenomenon of original antigenic sin, I choose
100 values of U2 logarithmically spaced between 10{3 and 1:0.
The minimum value Umin
2 ~10{3 reflects the case that memory
antibodies rarely recognize a new virus strain. The maximum
value Umax
2 ~1:0 corresponds to the immune response with the
highest memory antibody affinity. The intermediate values of U2
correspond to the case that memory antibodies have decreased
capability to recognize a new virus strain due to the escape
mutation of the strain or imperfect vaccination. One hundred
independent simulations were run with these 100 values of U2,
respectively. The maximum viral load and the maximum
percentage of dead cells were recorded for each simulation. The
cumulative effects of naı ¨ve antibodies and of memory antibodies
are respectively calculated with
XInt
1 ~
ð
X1 t ðÞ U1 t ðÞ dt ð9Þ
Table 2. Parameters of the dynamical model.
Physical meaning Parameter Parameter Estimation Unit
set 1 set 2
l Regeneration rate of healthy epithelial cells 2 day{1
b Infection rate 0.34 0.27 5:9|1010 M{1 day{1
a Death rate of infected epithelial cells 1.5 4.0 day{1
k Rate of virus release from infected epithelial cells 510 480 day{1
m Nonspecific virus clearance rate 1.7 3.0 day{1
p Rate of virus neutralization by antibodies 619.2 5:9|103 day{1
b Decay rate of antibodies 0.043 day{1
c0 Production rate of antibodies 1.0 1:7|10{11 M day{1
s Maturation rate of B cells 100 3:5|1014 M{1 day{1
doi:10.1371/journal.pone.0023910.t002
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2 ~
ð
X2 t ðÞ U2 t ðÞ dt: ð10Þ
Similarly, the average antibody affinity at the end of each
simulation is
Uavg~f
X1 t ðÞ U1 t ðÞ zX2 t ðÞ U2 t ðÞ
X1 t ðÞ zX2 t ðÞ
gjt~20: ð11Þ
Equation 11 calculates the average antibody affinity after the 20-
day period of time during which the patient recovered from the
infection. Note that indicated by equation 7, the naı ¨ve antibody
affinity U1 monotonically increases, while the memory antibody
affinity U2 is constant. Figure 3 depicts the maximum percentage
of dead cells, the maximum viral load, the cumulative effects of
naı ¨ve and of memory antibodies, and the final average antibody
affinity as the functions of the memory antibody affinity U2.
Figure 3a presents a picture of original antigenic sin with the
maximum percentage of dead cells. With U2~Umin
2 ~10{3, the
maximum percentage of dead cells, Dmax
0 ,i s30:6%. Original
antigenic sin is observed in the interval 10{3vU2v5:0|10{2.
The peak in the figure, 40.8%, is reached when U2~3:8|10{3 and
is 33.3% higher than the maximum percentage Dmax
0 ~30:6% with
U2~10{3. This 33.3% increase is significant for the percentage of
dead epithelial cells. When U2w0:1, the maximum percentage of
dead cells falls below 10%, indicating that no observable symptoms
occur in the infected person. That is, when the antigenic distance from
the previous infection or vaccination to the new virus strain is small,
the immune system can clear the virus effectively.
Figure 3b shows the non-monotonicity of the maximum viral
load V as a function of the memory antibody affinity U2 in the
process of virus infection and clearance. The maximum viral load
is Vmax
0 ~45:0 when Umin
2 ~10{3. The maximum viral load in the
region 10{3vU2v1:2|10{2 is higher than Vmax
0 ~45:0, and so
original antigenic sin occurs in this region. The maximum viral
load in the interval 1:6|10{3vU2v2:8|10{3 is at least twice
as high as Vmax
0 . With U2w0:11, the maximum viral load is less
than unity, agreeing with the fact that memory antibodies
effectively recognize and eliminate virus strains which are
antigenically similar to the immune memory [14].
Figure 3c describes the cumulative effects, XInt
1 and XInt
2 ,o f
naı ¨ve and memory antibodies in the process of virus infection and
clearance, respectively. The cumulative effects XInt
1 and XInt
2 are
calculated with equations 9 and 10, respectively. There is a
Figure 1. Time courses of the healthy cell concentration H ðÞ , the infected cell concentration I ðÞ , the dead cell concentration D ðÞ , the
viral load V ðÞ , the concentrations of naı ¨ve and memory antibodies X1 and X2 ðÞ , respectively, and the naı ¨ve antibody affinity U1 ðÞ .
The memory antibody affinity is U2~10{3. The initial conditions are H 0 ðÞ ~1, I 0 ðÞ ~D 0 ðÞ ~0, V 0 ðÞ ~0:01, X1 0 ðÞ ~10{4, X2 0 ðÞ ~10{2, and
U1 0 ðÞ ~10{3.
doi:10.1371/journal.pone.0023910.g001
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naı ¨ve antibodies XInt
1 is in a plateau in which XInt
1 w100. The
variable XInt
1 sharply decreases from 100 to 9:0|10{5 in a
narrow region 5:0|10{3vU2v9:3|10{3. The variable XInt
2
increases almost linearly with U2 from 7:7|10{3 (U2~10{3)t o
133.8 (U2~1:0). The variable XInt
1 is larger than XInt
2 when
U2v8:1|10{3 and is smaller otherwise. Because XInt
1 decreases
quickly when U2 is near U2~8:1|10{3, there is a large
difference between XInt
1 and XInt
2 when U2v5:0|10{3 or
U2w9:3|10{3. When U2v5:0|10{3, the naı ¨ve antibodies
are the dominant type of antibodies which makes the major
contribution to the clearance of influenza A virus. When
U2w9:3|10{3, the memory antibodies are the dominant type.
Figure 3d plots the final average antibody affinity Uavg against
the memory antibody affinity U2. Equation 7 ensures the
monotonic increase of U1, whereas the increase rate of U1
indirectly depends on U2. Similar to Figure 3c, a plateau with
Uavgw0:9 exists when U2v4:0|10{3, and Uavg decreases
substantially from 0.82 to 8:8|10{3 when U2 increases from
5:3|10{3 to 8:7|10{3. Note that in Figure 3c, this sudden
decrease in the cumulative effect of naı ¨ve antibodies XInt
1 occurs in
the same region of U2. When U2w8:7|10{3, Uavg increases
approximately linearly with U2, which is mainly due to the
contribution of the memory antibodies.
Mechanism of Original Antigenic Sin
The dynamical system defined by equations 2–7 can be split
into two subsystems, i.e. an actuator and a controller, with weak
coupling between them. Equations 2–4 constitute the actuator
with H, I, and V as the state variables. Equations 5–7 constitute
the controller with X1, X2, and U1 as the state variables. The
actuator is controlled by the variable E~U1X1zU2X2w0.
Therefore equation 4 is equivalent to
dV
dt
~kI{mV{pEV: ð12Þ
The actuator consisting of equations 2, 3, and 12 has two steady
states:
H ? ðÞ ,I ? ðÞ ,V ? ðÞ ðÞ 1~ 1,0,0 ðÞ
H ? ðÞ ,I ? ðÞ ,V ? ðÞ ðÞ 2~
a mzpE ðÞ
kb
,
l kb{a mzpE ðÞ ½ 
kb azl ðÞ
,
 
l kb{a mzpE ðÞ ½ 
b azl ðÞ mzpE ðÞ
 
:
By calculating the eigenvalues of the Jacobian of the actuator, I
find that the first steady state is stable for any Ew0, and the
Figure 2. Time courses of the healthy cell concentration H ðÞ , the infected cell concentration I ðÞ , the dead cell concentration D ðÞ , the
viral load V ðÞ , the concentrations of naı ¨ve and memory antibodies X1 and X2 ðÞ , respectively, and the naı ¨ve antibody affinity U1 ðÞ .
The memory antibody affinity is U2~0:5. The initial conditions are the same as those in Figure 1.
doi:10.1371/journal.pone.0023910.g002
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response is strong, E is large and the only steady state, H ? ðÞ , ð
I ? ðÞ ,V ? ðÞ Þ 1~ 1,0,0 ðÞ , indicates a complete recovery from the
infection. In the process of virus infection and clearance, a large
value of E ameliorates the infection of healthy cells by suppressing
virus proliferation. The numerical simulation of the actuator
illustrates the dependence on E of the dynamics of influenza A
infection. Figure 4 displays the effect of E: all the viruses are
cleared from the patient when E is larger than 0.18, and the decay
rates of the dead cell concentration D and of the viral load V
increase with E. Therefore, E is the only factor controlling the
values of D and V.
The other subsystem is the controller comprising the state
variables X1, X2, and U1. The controller observes the state of the
actuator as the factor c Z,t ðÞ , which jumps from 0 to c0 when the
viral load V reaches 0.1 and remains c0 for 14 days. Due to the
quick virus proliferation at the beginning of the infection, I let
c Z,t ðÞ ~c0~1 as an approximation. The dynamics of the
expression E are described by the following equation:
dE
dt
~
d
dt
U1X1zU2X2 ðÞ
~U2
d
dt
X1zX2 ðÞ zX1
dU1
dt
z U1{U2 ðÞ
dX1
dt
:
ð13Þ
The first term on the right hand side of equation 13,
U2d X1zX2 ðÞ =dt, is the product of U2 and the derivative of a
first order process X1zX2. The derivative of X1zX2 is obtained
by adding equation 5 to equation 6 with the approximation
c Z,t ðÞ ~1 and is independent of U2. The form of equations 5 and
7 shows that U2 suppresses the variables X1 t ðÞand U1 t ðÞ , and so
the term X1dU1=dt monotonically decreases with U2. In the case
of small U2, the factor U1{U2 ðÞ w0 in the process of virus
infection and clearance (see Figure 1), thus the third term
U1{U2 ðÞ dX1=dt decreases with U2. In the case of large U2, X1
is approximately constant, and the third term is negligible.
Consequently, the first term in equation 13 increases with U2
and the other terms decrease with U2. Figure 5 shows E as a
   
   
Figure 3. Trajectories of the maximum percentage of dead cells, the maximum viral load, the cumulative effects of naı ¨ve and
memory antibodies defined by equations 9 and 10, respectively, and the final average antibody affinity defined by equation 11
with different memory antibody affinities U2. The dashed horizontal lines in (a) and (b) are the maximum percentage of dead cells and the
maximum viral load, respectively, at the lowest memory antibody affinity U2~10{3.
doi:10.1371/journal.pone.0023910.g003
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in the second and third terms of E do not compensate the decrease
in the first term, yielding a suppression of E at intermediate U2.
The source of original antigenic sin is the interaction of the state
variables of the controller, or the immune system, modeled by
equations 5–7. When the memory antibody affinity U2 is either
low or high, naı ¨ve or memory antibodies are dominant,
respectively. If naı ¨ve antibodies are dominant, their final affinity
is high. At intermediate U2, the interaction and competition
between naı ¨ve and memory antibodies lead to a decreased
immune effect E, which clears the viruses less effectively. This is
original antigenic sin. When original antigenic sin occurs, the
influenza illness rate increases [14] due to the increases of D and
V during the process, and the average antibody affinity decreases
[17] due to the decrease of E. Note that the average antibody
affinity is defined as Uavg~E= X1zX2 ðÞ , where X1zX2 ðÞ are
approximately independent of U2, as discussed above.
Sensitivity Analysis
The parameters other than c0 and s come from literature. See
Table 2. As mentioned in the subsection Model Development
and Description, my model described by equations 2–7 can be
mapped from a previous dynamical model of influenza infection
and immune response [29], in which a comprehensive sensitivity
analysis for parameters is available. The sensitivity analysis for
most of the parameters in this model has been performed in [29].
So I first focus on two remaining parameters, c0 and s. The
parameter c0 characterizes the stimulation of the immune system
when the viral load increases beyond a threshold. Because this
paper aims to give a simplified model comprising the most
important factors of both epithelial cells and an immune system,
the effects of APC and Th2 cells are combined into the parameter
c0. The parameter s reflects the process of B cell somatic
hypermutation which produces antibodies with high affinity to
the antigens. Here I present a sensitivity analysis for the
parameters.
Figure 6 describes the behavior of the dynamical system with
different values of parameters c0 and s. The maximum
percentage of dead cells with large U2 is insensitive to s. The
average antibody affinity with small and large U2 is also
insensitive to both c0 and s, but is sensitive to intermediate U2.
If U2 is higher than a threshold, the memory antibodies play the
major role in the immune response; otherwise the naı ¨ve
antibodies mainly conduct the immune response. As shown in
Figure 6b and 6d, this threshold of U2 decreases with c0 and
increases with s. However, the dynamics with different values of
c0 and s in Figure 6 resemble those in Figure 3a and 3d. The
existence of original antigenic sin is insensitive to the parameters
Figure 4. Trajectories of the concentration of dead cells D ðÞ and the viral load V ðÞ with different effects of immune response E ðÞ . In
each trajectory, H 0 ðÞ ~1, I 0 ðÞ ~0, V 0 ðÞ ~100, and E is constant. When t??, viruses cannot be cleared at small values of E, such as 0.1. The decay
rates of both D and V increase with E.
doi:10.1371/journal.pone.0023910.g004
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percentage of dead cells and the average antibody affinity Uavg
are insensitive to the decay rate of antibodies (b) and the initial
concentration of memory antibodies (X2 0 ðÞ ). This sensitivity
analysis shows that the severity of an influenza A infection
decreases with c0, and the effect of original antigenic sin increases
with c0 and decreases with s.
Discussion
The model defined by equations 2–7 is a significant simplification
to the previous models describing the kinetics of influenza A infection
[25,29]. This model introduces a second type of antibodies, the
memory antibodies, to simulate the competition and cooperation
between naı ¨ve and memory antibodies. The contributions of Th1
cells, cytotoxic T lymphocytes (CTLs), interferons, and epithelial cells
protected by interferons are incorporated into the parameters of the
model. The contributions of APCs and Th2 cells, which together
activate B cells, are captured by the factor c Z,t ðÞ in a mean-field
approach, rather than being explicitly modeled using ODEs. The
presenting model has two limitations. First, at the same time of the
increase in the dead cell concentration D, the viral load V increases
by 103–104 fold and reaches the maximum on Day 1, which is
different from the experimental results of 104–105 fold increase at the
maximum on Day 2. Second, this model does not contain a term
modeling the loss of antibodies due to virus binding in equations 5
and 6. These limitations are due to simplification of the model.
However, these limitations do not seriously affect the emergence of
original antigenic sin in the model at intermediate memory antibody
affinity U2, the major topic of this study.
The concentration of CTLs increases by 100 times in the first
seven days after infection [25] to eliminate the infected cells. The
cellular immune system usually has strong cross immunity for
antigenically different influenza A virus strains [25], while the
humoral immune system cannot effectively recognize a new
influenza A virus strain with a large antigenic distance from the
previous strains seen by the host immune system [14]. Thus the
effects of CTLs against different influenza A virus strains are more
homogeneous than those of antibodies. That is, CTLs induced by
previous virus strains can effectively suppress a new virus strains
despite the escape mutation of the virus [25]. By contrast, the
antibody affinity decreases with the antigenic distance between the
previous virus strains and the new strain. Thus the contribution of
CTLs is more constant compared to that of antibody and can be
modeled by constant parameters to describe original antigenic sin.
For the same reason, the protection for healthy cells by the
interferon secreted by infected epithelial cells is not modeled as an
independent equation either. Additionally, the interferon and the
cells protected by the interferon are not the key factors of the
dynamics of virus infection and clearance: an absence of
interferons does not affect the final elimination of all viruses and
dead cells [29]. APCs and Th2 cells have little interaction with the
elements in the model other than the antibodies. Hence a simple
function c Z,t ðÞ is introduced to model the activation of B cells.
The present model contains two parts. Equations 2–4 constitute
a general model for an infection in tissue caused by a cytopathic
virus. Equations 5–7 define a model for the immune system which
recognizes and clears the virus. This model can be extended to
include the dynamics of CTLs and interferons in the immune
system. The model can also be extended to simultaneously
 
 
 
 
Figure 5. Trajectories of the effect of immune response, E~U1X1zU2X2. In each trajectory, H 0 ðÞ ~1, I 0 ðÞ ~0, V 0 ðÞ ~0:01,
X1 0 ðÞ ~10{4,X2 0 ðÞ ~10{2,and U1 0 ðÞ ~10{3. Each trajectory corresponds to one value of U2. When t??, viruses cannot be cleared at small
values of E, such as 0.1.
doi:10.1371/journal.pone.0023910.g005
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4 with different parameter sets l,b,a,k,m ðÞ to model each type of
virus. The cytopathic viruses fall into two categories: those causing
acute diseases and those causing chronic diseases. Viruses in the
first category, such as influenza A virus, are cleared in a short
period of time, thus relatively few escape mutations occur. The
immune system therefore directs itself towards a fixed target.
Equations 5–7 modeling the immune system do not require any
modification to take into account the escape mutation of the virus.
On the other hand, viruses in the second category, including HIV,
persist for years in the host and keep mutating away from the
immune system. A new set of ODEs are needed to model this case.
First, additional terms are required for equation 7 to describe the
decrease of the memory antibody affinity due to the escape
mutation of the virus. Second, if the immune system is also
infected by the virus, equations 5 and 6 should also contain terms
to model this infection. A similar model of the immune response
against HIV and the competition between antibodies has been
developed [39].
The currently available mathematical models of original
antigenic sin falls into two categories: stochastic models represent-
ed by the GNK model [17], and deterministic models as the
present one. Now I compare the mathematical form of the GNK
model [17] with that of my deterministic model. Both models
consider the contributions of naı ¨ve and memory B cells. Both
models explicitly simulate the competition between different types
of B cells. In the deterministic model, the maturation of naı ¨ve B
cells follows a logistic process. In the GNK model, the B cells have
random walks on a rugged and random landscape [17,19] where
the density of neighboring states with higher affinities decreases
with the affinity in the current state. The deterministic model has
two variables, U1 and U2, for the naı ¨ve and memory antibody
affinities, respectively. The GNK model, however, stores the
amino acid sequences of 1000 naı ¨ve antibodies and other 1000
   
 
 
     
 
 
 
 
 
     
 
 
     
 
 
 
 
 
Figure 6. Sensitivity analysis of parameters c0 and s. (a) and (b) The maximum percentages of dead cells and the average antibody affinities at
different values of c0. (c) and (d) The maximum percentages of dead cells and the average antibody affinities at different values of s. Initial conditions
and parameters other than c0 and s are the same as those in Figure 3.
doi:10.1371/journal.pone.0023910.g006
Understanding Original Antigenic Sin
PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23910memory antibodies [17]. After a simulation of 30 generations, the
number of different amino acid sequences generally converges to
less than five, similar to the deterministic model in which both
naı ¨ve and memory antibodies are considered as monoclonal.
There are parallels and differences between my deterministic
model and the GNK model [17], although these two models have
different mathematical forms as shown above. First, the deter-
ministic model uses the factors U1X1= U1X1zU2X2 ðÞ and
U2X2= U1X1zU2X2 ðÞ to model the selection of naı ¨ve and
memory B cells, respectively. In an immune response, B cells
producing antibodies with high binding affinity U1 or U2 are
selected. As a comparison, the stochastic model stores the amino
acid sequence of each B cell, selects those B cells with high affinity
to the antigen, and replicates the selected B cells to the next
generation. Second, the deterministic model simulates the B cell
maturation process with the factor c Z,t ðÞ describing the activation
of B cells. In the simulation, c Z,t ðÞ is greater than zero for 14 days,
in which the B cells compete for the antigen and divide. The
stochastic model repeats the process of B cell hypermutation and
selection for 30 generations of B cells, which correspond to the
primary or secondary immune response. Third, the naı ¨ve antibody
affinity in the deterministic model, U1, is modeled by equation 7, a
logistic equation. The increase rate of U1 decreases as U1
approaches to the maximum antibody affinity, Umax. The
stochastic model builds a rugged antibody affinity landscape, in
which the locations with high affinities have low density.
Consequently, the deterministic model is a mean-field approxi-
mation of the B cell maturation process. The deterministic model
is able to simulate original antigenic sin with reduced memory and
CPU requirement, while ignoring the amino acid sequence of each
B cell.
The dynamical model introduced in this paper is determin-
istic, while the process of influenza A infection and clearance is
stochastic in nature. However, the deterministic model gives
similar results as the stochastic models [16,17]. The deterministic
model assumes both naı ¨ve and memory antibodies to be
monoclonal. If either naı ¨ve or memory antibodies have multiple
amino acid sequences, the ODEs could be modified by
introducing more types of antibodies. Hence the competition
factors U1X1=(U1X1zU2X2) and U2X2=(U1X1zU2X2) could
   
 
 
     
 
 
 
 
 
     
 
 
     
 
 
 
 
 
Figure 7. Sensitivity analysis of parameters b and X2 0 ðÞ . (a) and (b) The maximum percentages of dead cells and the average antibody
affinities at different values of b. (c) and (d) The maximum percentages of dead cells and the average antibody affinities at different values of X2 0 ðÞ .
Initial conditions and parameters other than b and X2 0 ðÞare the same as those in Figure 3.
doi:10.1371/journal.pone.0023910.g007
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antibodies recognizing the antigen. By introducing the method
of splitting the dynamical system into an actuator and a
controller, the present model provides a starting point for the
application of nonlinear control theory to explain original
antigenic sin. The dynamical model can also be helpful to
rational vaccine design.
Materials and Methods
Kinetics of Influenza A Virus Infection
Influenza A virus infection can be described by a dynamical
process. The infection occurs in the epithelial cells on the surface
of upper respiratory tract in the bronchi with diameter larger than
3.3 mm [25]. The incubation period between the infection and the
emergence of symptoms ranges from one day to five days and is
typically two days. The host starts to shed infectious virus particle
approximately 24 hours prior to the emergence of symptoms. The
typical initial concentration of influenza A virus particles is
10{13 M. The viral load usually reaches a maximum 3|10{9 M
two days after infection and falls back to the initial level six days
after infection [25]. Influenza A virus is cytopathic and kills the
infected cells, causing the dead cells to accumulate in situ. The
percentage of dead epithelial cells reaches the maximum of 30–
50% on Day 2 and decreases to 10% on Day 5. If the maximum
percentage is lower than 10% in the process of virus infection and
clearance, no symptoms are observable [25]. The immune system
is activated by the detection of virus particles. The most important
suppressor of influenza A virus are antibodies IgG and IgA,
followed by the CD8 CTLs [37]. The concentrations of B cells and
of plasma cells increase by 102 times and 2|104 times,
respectively, within seven days [25]. The immune response to a
primary infection generates memory antibodies with binding
affinity 106 M{1 and concentration 10{13 M, constituting 0.1%–
1% of the total antibodies [29,37]. The naı ¨ve antibodies capable of
recognizing the antigen have the affinity 104 M{1 and concen-
tration 10{15 M [29,37], constituting 0.001%–0.01% of the total
antibodies.
Reduced Units and Parameter Estimation
I use reduced units for all the variables and parameters to make
their values close to unity and to facilitate the numerical
calculation. For the state variables H, I, V, X1, and X2, the unit
is defined as the homeostatic concentration of epithelial cells in the
upper respiratory tract, which is 1:7|10{11 M [25,29]. The unit
of U1 and U2 is defined as the maximum affinity between memory
antibodies and influenza A viruses, which is 1:0|107 M{1 [37].
The reduced units for all the variables in equations 2–7 are listed
in Table 1.
The majority of the parameters in this dynamical model are
obtained from previous experiments. These parameters fall into
two sets that are compatible with each other. The first set of
parameters were given by the publications [24,25,29,36]. These
publications depicted the process of influenza A virus infection and
clearance in the cellular level, taking into account the concentra-
tions of epithelial cells, viruses, APCs, interferons, Th1 and Th2
helper cells, CTLs, B cells, plasma cells, and antibodies. The
second set of parameters were extracted from an influenza A virus
infection experiment with six volunteers [27]. A simpler ODE
model with a fixed parametric form was built to fit the daily viral
loads data measured from nasal wash [27]. These two sets of
parameters in the reduced units are listed in Table 2. Despite the
different approaches to obtain the parameters, the parameters b,
a, k, and m from [24,25,29,36] and [27] are similar.
Compared to some previous models [25,29], a major simplifi-
cation in this study is neglecting the propagation of the activation
signal for the immune system, originated by the detection of the
virus and through APCs, Th2 cells, and B cells. Instead, I
introduce a time-dependent factor c Z,t ðÞ to model the activation
signal for the immune system in a mean-field approach. In a
typical process of influenza A virus infection, the viral load and the
concentration of APCs reach the maximum simultaneously on
Day 2 [25]. The viral load decreases to the initial level on Day 6
[25]. As listed in Table 3, the half-lives of APCs, helper T cells, B
cells, and plasma cells are similar to the duration of the infection.
Thus the duration of B cell maturation process is estimated to be
14 days, longer than the duration of viral clearance. Accordingly,
the factor c Z,t ðÞ has the initial value of zero, is assigned the value
c0 when V reaches 0.1, and equals to c0 for 14 days before
decreasing to zero again. Using the output of the previous models
[25,29], I estimate the parameter c0 to be 1.0, and the parameter s
to be 100.
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